ROSUVOLITE – F
Category: Hypolipidemic Combination
Composition: Rosuvastatin 10 mg + Fenofibrate 160 mg

Overview
Combination therapy for mixed dyslipidemia and elevated triglycerides where clinically appropriate.

Mechanism of Action
Rosuvastatin inhibits cholesterol synthesis; Fenofibrate activates PPAR-α to improve triglyceride metabolism.

Key Clinical Uses
• Lowers LDL and triglycerides.
• Raises HDL cholesterol.
• Comprehensive lipid management.

Dosage Form : Film-coated tablet

Storage
Store below 30°C in a cool, dry place. Protect from moisture and keep out of reach of children.

Disclaimer
For use by registered medical practitioners only. Prescribe according to the approved prescribing information.